EP. 1: Nab-Sirolimus and Its Role in PEComa Treatment
Jacob Stein, MD, MPH, discusses how nab-sirolimus improves outcomes for patients with advanced perivascular epithelioid cell tumors compared with other treatments or no treatment options.
EP. 2: Exploring the Benefits of Nab-Sirolimus in Advanced PEComa Treatment
In an interview with Targeted Oncology, Jacob Stein, MD, MPH, discussed nab-sirolimus and its impact on patients with advanced PEComa.
